Fund has not been able to generate better returns than other funds in same sector
Fund has outperformed its benchmark index
Less expense ratio implies better returns over the long term
Fund has not been able to generate better price return than bank FD
Stocks in portfolio are not in ASM/GSM lists, not a lot of promoter holding is pledged and default probability is low
Sector Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.
Gains are treated as short-term capital gains and taxed at 15%
Gains of over ₹ 1 lakh in a financial year are taxed at 10%
Expected growth rate
Reliance Nippon Life Asset Management or RNAM is one of India’s two largest asset management companies. Currently, it has over $60 billion in its corpus. It is a wholly owned subsidiary of the Reliance Anil Dhirubhai Ambani or ADA Group.
₹ 1,90,364.58 Cr.